Saturday, 13 February 2016 14:58

Anticoagulation news items. Weeks commencing 8th February 2016

Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54

European Heart Journal

This review on dual antiplatelet therapy (DAPT) discusses the implications of the PEGASUS-TIMI 54 study which showed that patients with a history of ACS and at high risk of further ischaemic events, may benefit from prolonged ticagrelor-based DAPT.


Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism

Cochrane Database of Systematic Reviews

Moderate to high quality evidence suggests that there are no differences between these agents and standard anticoagulation for long-term treatment of PE for the outcomes recurrent PE, recurrent venous thromboembolism, DVT, all-cause mortality and major bleeding.




The above records have been identified by UKMi and feature in the NICE Medicines Awareness Service. Further details on this service can be found at: